U.S. market Closed. Opens in 1 day 5 hours 31 minutes

AKTX | Akari Therapeutics, Plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue4.00K3.71K4.12K8.91K19.20K35.85K42.40K39.77K10.16KN/AN/AN/AN/AN/A
Gross Profit-4.00K-3.71K-4.12K-8.91K-19.20K-35.85K-42.40K-39.77K-10.16KN/AN/AN/AN/AN/A
Operating Expenses16.81M23.89M17.21M20.10M24.89M23.80M34.96M27.25M11.30M10.18M3.61M1.75M2.25M792.00K
Selling, General & Admin11.36M13.53M8.08M7.91M8.22M10.90M11.67M9.94M5.50M3.76M2.33M734.00K1.41M545.00K
Research & Development12.13M9.56M9.13M12.19M16.65M15.59M23.29M17.31M5.80M6.42M1.28M1.02M841.00K247.00K
Other Operating Expenses-6.68M802.79K-27.48K-22.01K19.00K-2.68M-13.39K-43.97K-44.22KN/AN/AN/AN/AN/A
Operating Income-16.81M-23.09M-17.21M-17.98M-24.87M-19.99M-34.96M-27.25M-30.58M-10.18M-3.61M-3.67M-2.25M-792.00K
Other Expenses / Income6.80M5.34M-210.10K899.36K-142.67K-507.93K2.38M9.11M-14.72M567.57K-14.00K2.23M128.00K117.00K
Before Tax Income-10.01M-17.75M-17.42M-20.45M-24.75M-23.50M-32.57M-18.14M-45.32M-9.65M-3.62M-1.44M-2.12M-675.00K
Income Tax ExpensesN/A-10.78M182.62K-2.86M-2.99M-3.55M-4.65M-43.97K3.01MN/A202.00K1.92M9.00KN/A
Net Income-10.01M-6.97M-17.61M-17.60M-21.76M-19.95M-27.92M-18.14M-45.32M-9.65M-3.62M-1.44M-2.12M-675.00K
Interest ExpensesN/AN/AN/AN/AN/AN/AN/A9.15M3.05MN/A202.00K1.04MN/A5.00K
Basic Shares Outstanding4.89M3.12M2.15M1.58M915.50K15.81M12.47M11.78M8.52M855.16K210.75K124.59K133.70K133.70K
Diluted Shares Outstanding4.89M3.12M2.15M1.58M915.50K15.81M12.47M11.78M8.52M855.16K210.75K124.59K133.70K133.70K
EBITDA-16.80M-23.08M-17.21M-20.44M-24.73M-16.43M-35.36M-27.25M-19.28M-10.19M-3.42M-3.36M-2.12M-675.88K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-10.01M-17.75M-17.42M-20.45M-24.75M-23.50M-32.57M-9.04M-39.25M-9.65M-3.22M1.52M-2.11M-670.00K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙